08:24 AM EDT, 08/28/2024 (MT Newswires) -- Biora Therapeutics ( BIOR ) said Wednesday it was granted an extension by Nasdaq to regain compliance with the exchange's listing requirements.

The company said Nasdaq's hearings panel granted a request for continued listing subject to its compliance with the $50 million market value minimum for listed securities and $1 bid price requirement by Nov. 7.